Neurology 1602 - Neurology Alert - Feb 01, 2012

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
John J. Caronna, MD
Professor of Clinical Neurology
Weill Cornell Medical College

Michael Rubin, MD, FRCP(C)

Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Authors

Melissa J. Nirenberg, MD, PhD
Associate Professor
Neurology and Neuroscience
Weill Cornell Medical College

Joseph E. Safdieh, MD
Assistant Professor of Neurology
Weill Cornell Medical College

Steven Karceski, MD
Director of Clinical Trials
Cornell Comprehensive Epilepsy Center
Weill Cornell Medical College

Subjects:

  • Solvents and the Risk of Parkinson's Disease
  • Another Major Syndrome of the Minor Hemisphere — Othello Syndrome
  • Cortical Lesions are an Important Component of Multiple Sclerosis
  • Muscle Complications Due to Statins
  • CLIPPERS: Is it for Real?
  • Posterior Reversible Encephalopathy Syndrome, Seizures, and the EEG

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Authors Melissa J. Nirenberg, MD, PhD, Joseph E. Safdieh, MD, assistant editors John J. Caronna, MD, Michael Rubin, MD, FRCP(C), peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Author Timothy Vartanian, MD, PhD reports that he is on the speakers bureau for UCB Pharma and Cyberonics. Author Steven Karceski, MD reports he is on the speakers bureau for GlaxoSmithKline, Cyberonics, and Pfizer; and receives research support form Novartis and Cyberonics.

Copyright 2012 AHC Media LLC. All rights reserved.